채용
Benefits & Perks
•Healthcare
•Equity
•401(k)
•Healthcare
•Equity
•401k
Required Skills
Molecular biology
NGS assay development
Sample preparation
Library preparation
Target capture
Sequencing
Automated platforms
Liquid handling
Data analysis
Manual pipetting
About this opportunity:
At Freenome, we are seeking a Research Associate II to help grow the Freenome Genomics Late Stage Development team. The ideal candidate is highly analytical and detail-oriented, with a strong foundation in molecular biology and knowledge of next-generation sequencing (NGS) technologies. This person is responsible for all things related to developing and validating clinical-grade assays to measure complex, blood-based analytes (e.g., whole-genome sequencing of cfDNA). You are passionate about advancing cancer diagnostics, and you will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
The role reports to the Manager of Genomics Late Stage Development. This role will be an onsite role based in our Brisbane, California headquarters.
What you’ll do:
-
Apply knowledge of molecular biology, nucleic-acid biochemistry, and next-generation sequencing to develop assays for DNA, including genome-wide and targeted approaches.
-
Characterize automated assays by generating and analyzing experimental data.
-
Create and manipulate high impact assay inputs, including samples and reagents formulation as required.
-
Gather high-quality data, take detailed notes, and openly communicate on lessons learned while performing experiments.
-
Collaborate with development team and computational biologists, analyze data and generate study conclusions.
-
Collaborate with clinical laboratory members to transition development protocols into production, including automation, validation experiments, and SOP development.
-
Present data in cross functional teams.
-
Contribute to study protocols and reports.
Must haves:
-
Bachelors with 2+ years of relevant industry experience or Masters in molecular biology, or a related field.
-
Hands-on experience in NGS based assay development including sample preparation, library preparation, target capture, and sequencing.
-
Experience with automated platforms in plate-based, low-volume formats and/or microfluidics and experience working with automated liquid handlers.
-
Biological understanding of human cell-free nucleic acids and/or cancer biology.
-
High attention to detail and ability to record accurate and detailed observations, assess impact, and perform troubleshooting as required.
-
Flexible and highly motivated to learn new skills and comfortable adapting to changing priorities.
-
Ability to manual pipette with high confidence, accuracy, and precision.
-
Clear and proactive communication skills and ability to collaborate effectively with team members in the same and adjacent disciplines.
Nice to haves:
-
Experience working in a regulated laboratory environment (CLIA, GLP/GCLP, IVD development).
-
Experience using ELN (electronic lab notebook) and LIMS (lab information management system).
-
Familiarity with programing in a scientific programming language (e.g., Python or R).
Benefits and additional information:
The US target range of our hourly rate for new hires is $31.67 - $49.52. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
*Applicants have rights under Federal Employment Laws. *
-
Family & Medical Leave Act (FMLA)
-
Equal Employment Opportunity (EEO)
-
Employee Polygraph Protection Act (EPPA)
#
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Tech Lead/Manager, Machine Learning Research Scientist- LLM Evals
Scale AI · San Francisco, CA; Seattle, WA; New York, NY

Macro & Credit Research Economist
Plaid · San Francisco

Graduate Research Internship, Electrolyte Development
Sila Nanotechnologies · Alameda, CA

Deep Research Agent Tech Lead
Scale AI · San Francisco, CA; New York, NY

UBRI Research Associate Intern, Ripple Impact (Summer 2026)
Ripple · New York, NY, United States
About Freenome

Freenome
Series CFreenome is a biotechnology company that develops blood-based tests for early cancer detection using artificial intelligence and genomics.
201-500
Employees
South San Francisco
Headquarters
$2.3B
Valuation
Reviews
3.8
1 reviews
Work Life Balance
2.5
Compensation
3.0
Culture
4.0
Career
2.5
Management
2.0
60%
Recommend to a Friend
Pros
Fantastic science and mission
Great people and team
Meaningful work
Cons
Leadership struggles with decision making
Lack of concrete planning
Recent layoffs impacting teams
Salary Ranges
33 data points
Senior/L5
Senior/L5 · Senior Supply Chain Data Analyst
1 reports
$155,250
total / year
Base
$135,000
Stock
-
Bonus
-
$155,250
$155,250
Interview Experience
46 interviews
Difficulty
3.1
/ 5
Duration
14-28 weeks
Offer Rate
38%
Experience
Positive 69%
Neutral 16%
Negative 15%
Interview Process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Common Questions
Technical skills
Past experience
Team collaboration
Problem solving
News & Buzz
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection - PR Newswire
Source: PR Newswire
News
·
7w ago
Peninsula company rides blank check to Wall Street after raising more than $1 billion as a startup - The Business Journals
Source: The Business Journals
News
·
12w ago
Freenome inks deals to list stock and raise $330M - MedTech Dive
Source: MedTech Dive
News
·
12w ago
Cancer detection firm Freenome to go public via $330 million SPAC deal - statnews.com
Source: statnews.com
News
·
13w ago